Tuberculosis Assayed by MODS (Microscopic-Observation Drug
Tuberculosis Assayed by MODS (Microscopic-Observation Drug
Tuberculosis Assayed by MODS (Microscopic-Observation Drug
Comparison of drug susceptibility pattern of Mycobacterium tuberculosis assayed by MODS (Microscopic-observation drugsusceptibility) with that of PM (proportion method) from clinical isolates of North East India
Leimapokpam Shivadutta Singh1, Pranab Behari Mazumder2, Gauri Dutt Sharma3
1 1
(Department of Biotechnology, Assam University, Silchar (Department of Biotechnology, Assam University, Silchar 3 (Bilaspur University, Bilaspur
About one third of the worlds population are infected with tuberculosis and has become a serious global concern of public health. The major problem in controlling tuberculosis is the rapidity and efficacy of detection methods adopted. This study was conducted with the objective to compare the drug susceptibility pattern of Mycobacterium tuberculosis assayed by MODS (Microscopic-observation drugsusceptibility) with that of PM (proportion method) from clinical isolates of North East India. A total of 150 smear positive sputum specimens clinical isolates of M. tuberculosis referred to a clinical lab wa selected. Both the proportion method and MODS were conducted for the collected isolates. DST of MODS were compared with that of PM considering PM as gold standard. MODS detected INH, RIH, STR and EMB resistant isolates at 31% (n = 46/150), 29% (n = 49/150), 19.3& (n = 29/150) and 27.3% (n = 41/150), respectively .Specificity was very high for all the drugs resistance with more than 99% specificity. The accuracy, PPV and NPV of MODS in detection of the four drug resistant isolates was relatively high. DST assay by MODS is relatively simpler. The appreciable performance characteristic in detecting drug resistance including MDR TB may lead to its wider applications in different labs and general hospital for resource limited regions.
ABSTRACT:
I.
INTRODUCTION
Tuberculosis arouses public health concern and became a global burden. It is about one third of the population of the world are infected with tuberculosis. AIDS and the increase incidence of multidrug resistant tuberculosis are the major factors that contribute to tuberculosis epidemic. In 2012, 8.6 million people fell ill with TB and 1.3 million died (WHO, 2013).TB occurs in every part of the world. In same year the largest number of new TB cases occurred in Asia, accounting for 60% of new cases globally. However, sub-Saharan Africa carried the greatest proportion of new cases per population with over 255 cases per 100000 populations in 2012 (WHO, 2013). In 2012, about 80% of reported TB cases occurred in 22 countries. Some countries are experiencing a major decline in cases, while cases are dropping very slowly in others (WHO.2013). India is classified along with the sub-Saharan African countries to be among those with a high burdenfor tuberculosis as well as drugresistant tuberculosis (WHO, 2012). Though India is the second-most populous country in the world, India has more new TB cases annually than any othercountry. In 2011, out of the estimated global annual incidence of 9 million TB cases, 2.3 million were estimated to haveoccurred in India (WHO, 2013).The nature and frequency of mutations in the resistant strains vary significantly based on the geographical location (Mokrousov et al, 2002). In this regard, here is very less information available on specific mutational patterns in India (Sharma et al, 2003), let alone on the underdeveloped and isolated region of northeast India. MDR TB strains have been reported mostly from countries where HIV and TB co-infection is endemic which includes India (Prasad, 2005).
II.
2.1
Study settings The clinical isolates referred to the Babina Diagnostic Centre in Imphal, Manipur were taken up for the present study. In order to strengthen the rapid detection of drug susceptibility of Mycobacterium tuberculosis at resources limited and high burden region the study was carried out. 2.2 Sputum specimens One hundred and fifty sputum samples were collected for this study. Entire handling of the clinical specimens was performed inside a Class II safety cabinet in a BSL2 laboratory in accordance with CDC guidelines. Sputum decontaminations were carried out with the conventional N-acetyl-L-cysteine-NaOH. After centrifugation, the pellet was suspended in 1ml of 85% NaCl. All specimens were processed for acid fast microscopy using Ziel-Neesen technique (Canetti et al, 1963; Kent &Kubica, 1985). Sputum samples showing more than 10 acid fast bacilli (AFB) per microscopic field in the smear were selected for the study. 2.3 Critical concentration of antibiotics in Drug Susceptibility Testing The critical concentration of antibiotics which is given below Table.1 were maintained as per prescribed norms for indirect DST assay for PM and MODS methods. Table.1. Critical concentration of antibiotics in Drug Susceptibility Testing Drugs Isoniazid (INH) Rifampicin (RMP) Streptomycin (STR) Ethambutol (EMB) Critical Concentration (g/ml) 0.2 40 4 2
2.4 Proportion method 2.4.1 Culture preparation: Lowenstein - Jensen Medium is used with fresh egg and glycerol for the culture of Mycobacterium spp.
Statistical methods were performed using SPSS 17.0. Results were considered significant at P value less than 0.5
III.
RESULTS
Table 3 below shows the result of DST to the four drugs for PM tested on 150 isolates. Of the total sample, isolates showing resistance to RIH, INH, STR and EMB were 28%(n = 42/150), 31.3%(n = 47/150), 21%(n = 31/150) and 28%(n = 47/150) respectively by PM. Out of the 150 isolates, 26 were detected as MDR due to resistance to both INH and RIH while 16 were monoresistant to RIH and and 21 were monoresistant to INH Table 4). The results of the PM are taken as gold standard for comparison to that of MODS. Table 3.Drug susceptibility pattern by proportion method NAME OF DRUGS RESISTANT SENSITIVE RIFAMPICIN ISONIAZID STREPTOMYCIN ETHAMBUTOL 42 47 31 42 108 103 119 108
Table 4.MDR detection by proportion method Number of strains (n = 150) 87 Susceptible 16 RIH mono resistant 21 INH mono resistant 26 MDR
Direct drug susceptibility testing results on MODS were compared with indirect DST on LJ as the gold standard for 150 samples. MODS detected INH, RIH, STR and EMB resistant isolates at 31% (n = 46/150), 29% (n = 49/150), 19.3& (n = 29/150) and 27.3% (n = 41/150), respectively shown in Table 3. A comparison of the sensitivity of the four drugs in MODS shows a relatively low percentage in STR (93.5%) with high value in RIH (100%). Specificity was very high for all the drugs resistance with more than 99% specificity. The accuracy, PPV and NPV of MODS in detection of the four drug resistant isolates given in Table 6.
IV.
DISCUSSION
Our data shows that MODS is a sensitive and rapid method for diagnosis of TB and DST pattern. The sensitivities in detection of INH and RIH resistance in our study were lower than those from the study of Moore at el 2000 (72.6% vs 84.6% for INH and 72.7% vs 100% for RIH) although both studies used the same INH concentration (0.4g/ml) and RIF concentration (1g/ ml). These concentrations have been recommended in the MODS guidelines from the MODS development team in Peru (Jorge et al; 2009. However, a recent metaanalysis published after completion of this study concluded that the sensitivity of INH-resistance detection was higher with a concentration of 0.1g/ml without loss of specificity (Minion et al., 2010).The only equipment needed to perform the MODS assay are an inverted microscope, tissue culture plate and consumables, biological safety cabinet and incubator. The technical competence required is aseptic technique and microscopy skills. A commercial MODS plate (TB MODS kit) has been developed by Hardy Diagnostics, USA in collaboration with PATH and is under evaluation.
V.
CONCLUSION
In conclusion MODS is appropriate for screening for DST pattern in high burden countries where such tests are urgently needed. MODS meets many criteria for an DST diagnostic test applicable for high-burden settings; it is rapid, low cost and accurate and can be performed without the need for biological safety level 3 laboratories (if the plate is not opened after inoculation). Therefore, MODS is an alternative method for rapid DST screening inthese settings. Recently, wide application of MODS in resource-constrained settings has been endorsed by WHO [2011]. However, an international standard operating procedure and a quality assurance system accredited by WHO should be developed to standardize and maintain accuracy.
The authors would like to thank the technical and administrative staff of Babina Diagnostic Clinic for their support in this research. REFERENCES
[1] [2] [3] Canetti G, Froman S, Grosset J, Haudway P, Langerova M, Mahler H T, Meissner G, Mitchison D A and Sula L. Mycobacteris: Laboratory methods for testing drug sensitivity and resistance. Bull. World Health Organ. 1963; 29: 565 578. Caviedes L, Deelgado J and Gilman R H. Tetrezoliummicroplate assay as rapid and inexpensive clorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis. J. Clin. Microbiol. 2002; 20(40:5):1873 1874. Jorge Coronel MR, Luz Caviedes, David Moore: MODS - A USER GUIDE -Microscopic Observation drug Susceptibility Assay. v12. 114082008. Available at http://www.modsperu.org/MODS userguide.pdf.Accessed Jan 13rd 2009, vol. v12.114082008. Lima - Peru; 2008 Kent, P.T., Kubica, G.P. Public Health Mycobacteriology. A Guide for the Level III Laboratory. US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta. 1985. Leimapokpam Shivadutta Singh, Pranab Beheri Mazumder and Gauri Dutt Sharma. Analysis of mutational pattern in multidrug resistant tuberculosis (MDR TB) in a geographically isolated north eastern region of India. IOSR Journal of Pharmacy and Biological Sciences.2014;9:4-10. Microscopic Observation drug Susceptibility Assay. v12.114082008., Available at http://www.modsperu.org/MODS_user_guide.pdf. Accessed Jan 13 rd 2009, vol. v12.114082008. Lima - Peru; 2008. Minion J, Leung E, Menzies D, Pai M: Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10(10):688-698. Mokrousov I, Narvskaya O, Otten T, Limenschenko E, Steklova L, Vyshnevskiy B. High prevalence of katG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from Northwestern Russia, 1996-2001. Antimicrob Agents Chemother 2002; 46:14171424. Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, et al.Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med. 2006 Oct 12; 355(15):1539-50. National AIDS Control Organisation (NACO), Dept. of AIDS control, Ministry of Health and Family Welfare. Annual Report 2011-2012. Prasad R. MDR-TB: current status. Indian. J. Tub.2005; 52:121 131. Sarman Singh, Parveen Kumar, Shreya Sharma, Francis Mumbowa, AnandiMartin,and Nicolas Durie. Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-Commercial Assays: Part 1: Microscopic Observation Drug Susceptibility Assay v2.4.12.J Lab Physicians.2012.4 (2): 101111. Sharma M, Sethi S, Mishra B, Sengupta C and Sharma S K. Rapid detection ofmutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay. Indian J. Med. Res. 2003; 117: 76 80. World health Organisation. Global tuberculosis control report. Geneva, Switzerland: WHO, 2011. World health Organisation. Global tuberculosis control report. Geneva, Switzerland: WHO, 2012. World health Organisation. Global tuberculosis control report. Geneva, Switzerland: WHO, 2013.
[4] [5]